Amphastar Pharmaceuticals Inc Aktie News

Nettoumsatz von 183,9 Mio. USD für die drei Monate zum 30. Juni 2026 GAAP-Nettogewinn von 30,3 Mio. USD bzw. 0,67 USD pro Aktie für das zweite Quartal Bereinigter Non-GAAP-Nettogewinn von 40,8 Mio. USD bzw. 0,91 USD pro Aktie für das zweite Quartal Unternehmen wird heute um 14:00 Uhr pazifischer Zeit eine Telefonkonferenz abhalten RANCHO CUCAMONGA, Calif.

Trump plant Zölle von bis zu 200 % auf importierte Generika nach einer zweijährigen Schonfrist, die die US-Produktion fördern soll. Doch die geringen Gewinnmargen machen Zölle schwerer verkraftbar als bei Markenmedikamenten, und zentrale politische Details bleiben unklar.

SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating whether Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) or certain of its executive officers violated federal securities laws. The investigation focuses on investors' losses and whether they may be recovered under federal securities laws.

RANCHO CUCAMONGA, CA / ACCESS Newswire / May 27, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, will be presenting at the 2026 Jefferies Healthcare Conference on Wednesday, June 3, 2026, at 4:55 p.m. ET. For access to the webcast, visit Amphastar Pharmaceuticals' website at http://ir.amphastar.com.

Amphastar Pharmaceuticals NASDAQ: AMPH executives said the company is taking steps to address rebate and discounting pressure on BAQSIMI while maintaining its full-year revenue outlook, according to remarks at the BofA Annual Healthcare Conference.

Net revenues of $171.2 million for the three months ended March 31, 2026 GAAP net income of $6.4 million, or $0.14 per share, for the first quarter Adjusted non-GAAP net income of $19.5 million, or $0.42 per share, for the first quarter Company to hold a conference call today at 2:00 p.m. Pacific Time RANCHO CUCAMONGA, CA / ACCESS Newswire / May 7, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ...

RANCHO CUCAMONGA, CA / ACCESS Newswire / May 6, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Tony Marrs, EVP of Regulatory Affairs and Clinical Operations, will be presenting at the 2026 Bank of America Health Care Conference on Wednesday, May 13, 2026, at 3:00 pm PT. For access to the webcast, visit Amphastar Pharmaceuticals' website at http:/...